4/11
08:10 am
hrtx
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $4.00 price target on the stock.
Medium
Report
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $4.00 price target on the stock.
4/11
06:42 am
hrtx
Rating for HRTX
Medium
Report
Rating for HRTX
4/11
06:42 am
hrtx
Rating for HRTX
Medium
Report
Rating for HRTX
2/28
08:13 am
hrtx
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $4.00 price target on the stock.
High
Report
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $4.00 price target on the stock.
2/28
05:13 am
hrtx
Rating for HRTX
High
Report
Rating for HRTX
2/28
05:13 am
hrtx
Rating for HRTX
High
Report
Rating for HRTX